| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |